Exponent Inc (NASDAQ:EXPO)
| Market Cap | 3.34B+3.5% |
| Revenue (ttm) | 632.46M+12.8% |
| Net Income | 111.77M+8.7% |
| EPS | 2.23+11.5% |
| Shares Out | 48.51M |
| PE Ratio | 30.92 |
| Forward PE | 26.22 |
| Dividend | $1.23(1.78%) |
| Ex-Dividend Date | Sep 4, 2026 |
| Volume | 683,716 |
| Open | 68.91 |
| Previous Close | 69.18 |
| Day's Range | 68.31 - 69.90 |
| 52-Week Range | 51.91 - 81.95 |
| Beta | 0.70 |
| Analysts | Buy |
| Price Target | 72.00(+4.42%) |
| Earnings Date | Oct 29, 2026 |
EXPONENT INC has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About EXPO
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$EXPO stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in EXPO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EXPO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EXPO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EXPO Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Engineering and Other Scientific | $148.83M | 86.72% |
| Environmental and Health | $22.78M | 13.28% |
As of: Q3 2026 (Jul 3, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EXPO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EXPO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in EXPO
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $109.57M |
| IWMiShares Russell 2000 ETF | $88.64M |
| VBVanguard Morningstar Small-Cap ETF | $79.22M |
| SDVYFirst Trust SMID Cap Rising Dividend Achievers ETF | $73.88M |
| PAVEGlobal X - U.S. Infrastructure Development ETF | $50.71M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $45.51M |
Estimated from each fund’s disclosed top holdings × AUM
EXPO Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EXPO’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score